I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Kriachok, Iryna
26
results:
Search for persons
X
Format
Online (26)
Mediatypes
Articles (Online) (10)
OpenAccess-fulltext (16)
Languages
english (24)
Sorted by: Relevance
Sorted by: Year
?
1
CHRONOS-4: Phase 3 study of copanlisib plus rituximab-based..:
Zinzani, Pier Luigi Luigi
;
Wang, Huaqing
;
Feng, Jifeng
...
Blood Advances. , 2024
Link:
https://doi.org/10.1182/..
?
2
Distribution of lymphoma subtypes in Ukraine according to t..:
Kriachok, Iryna
;
Stepanishyna, Yana
;
Skrypets, Tetiana
...
Hematological Oncology. 41 (2022) 1 - p. 196-200 , 2022
Link:
https://doi.org/10.1002/..
?
3
Acalabrutinib Versus Investigator's Choice in Relapsed/Refr..:
Ghia, Paolo
;
Pluta, Andrzej
;
Wach, Małgorzata
...
HemaSphere. 6 (2022) 12 - p. e801 , 2022
Link:
https://doi.org/10.1097/..
?
4
Effect of prior treatments on selinexor, bortezomib, and de..:
Mateos, Maria V.
;
Gavriatopoulou, Maria
;
Facon, Thierry
...
Journal of Hematology & Oncology. 14 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1186/..
?
5
Effect of age and frailty on the efficacy and tolerability ..:
Auner, Holger W.
;
Gavriatopoulou, Maria
;
Delimpasi, Sosana
...
American Journal of Hematology. 96 (2021) 6 - p. 708-718 , 2021
Link:
https://doi.org/10.1002/..
?
6
Peripheral neuropathy symptoms, pain, and functioning in pr..:
Sanchez, Larysa
;
Leleu, Xavier
;
Beaumont, Jennifer L.
...
American Journal of Hematology. 96 (2021) 10 - p. , 2021
Link:
https://doi.org/10.1002/..
?
7
Selinexor, bortezomib, and dexamethasone versus bortezomib ..:
Richard, Shambavi
;
Chari, Ajai
;
Delimpasi, Sosana
...
American Journal of Hematology. 96 (2021) 9 - p. 1120-1130 , 2021
Link:
https://doi.org/10.1002/..
?
8
PROGNOSTIC VALUE OF IMMUNOHISTOCHEMICAL MARKERS IN PATIENTS..:
Martynchyk, Arina
;
Gurianov, Vitaliy
;
Kriachok, Iryna
EUREKA: Health Sciences. 1 (2018) - p. 26-33 , 2018
Link:
https://doi.org/10.21303..
?
9
THE COMPLICATIONS OF DIFFERENTIAL DIAGNOSTICS OF HODGKIN LY..:
Kriachok, Iryna
;
Ulianchenko, Katerina
EUREKA: Health Sciences. 6 (2016) - p. 63-68 , 2016
Link:
https://doi.org/10.21303..
?
10
Acalabrutinib Versus Investigator's Choice in Relapsed/Refr..:
Ghia, Paolo
;
Pluta, Andrzej
;
Wach, Malgorzata
...
HemaSphere. -6 : 12 (2022), p. 1-10. -Hemasphere. - 2572-9241. , 2022
Link:
https://hdl.handle.net/2..
?
11
Distribution of lymphoma subtypes in Ukraine according to t..:
Kriachok, Iryna
;
Stepanishyna, Yana
;
Skrypets, Tetiana
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087250/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
12
Acalabrutinib Versus Investigator's Choice in Relapsed/Refr..:
Ghia, Paolo
;
Pluta, Andrzej
;
Wach, Małgorzata
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666115/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
13
Effect of prior treatments on selinexor, bortezomib, and de..:
Mateos, Maria V
;
Gavriatopoulou, Maria
;
Facon, Thierry
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045319/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
14
Selinexor, bortezomib, and dexamethasone versus bortezomib ..:
Richard, Shambavi
;
Chari, Ajai
;
Delimpasi, Sosana
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457116/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
15
Effect of Age and Frailty on the Efficacy and Tolerability ..:
Auner, Holger W
;
Gavriatopoulou, Maria
;
Delimpasi, Sosana
...
American Journal of Hematology. , 2021
Link:
http://hdl.handle.net/10..
1-15